Mednet Logo
HomeGynecologic OncologyQuestion

With the addition of pembrolizumab following chemoradiation per KEYNOTE-A18, would you be less likely to treat the paraaortic chain prophylactically?

2
1 Answers
Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

I would favor the same volume of RT with or without pembro. If there is an indication to treat PA nodal chain, would treat as per plan.

Register or Sign In to see full answer

With the addition of pembrolizumab following chemoradiation per KEYNOTE-A18, would you be less likely to treat the paraaortic chain prophylactically? | Mednet